Differential cardiovascular profiles of sodium-glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin.

about

SGLT2 inhibitors as add on therapy in type 2 diabetes: a real world study Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017.

P2860

Q33859212-120D9687-9142-48E3-8F29-89D31E1ECF01 Q55207460-FAAD7CDC-02C7-4B4E-AF31-F41FB979FD9D

P2860

Differential cardiovascular profiles of sodium-glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin.

Item

http://www.wikidata.org/entity/Q39300057

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Differential cardiovascular pr ...... l evaluation of empagliflozin.

@en

Differential cardiovascular pr ...... l evaluation of empagliflozin.

@nl

type

Item

label

Differential cardiovascular pr ...... l evaluation of empagliflozin.

@en

Differential cardiovascular pr ...... l evaluation of empagliflozin.

@nl

prefLabel

Differential cardiovascular pr ...... l evaluation of empagliflozin.

@en

Differential cardiovascular pr ...... l evaluation of empagliflozin.

@nl

P1476

Differential cardiovascular pr ...... l evaluation of empagliflozin.

@en

P2093

Robert Chilton

http://www.w3.org/2001/XMLSchema#string

Ruben Rodriguez

http://www.w3.org/2001/XMLSchema#string

Saurabh Sanon

http://www.w3.org/2001/XMLSchema#string

Shalin Patel

http://www.w3.org/2001/XMLSchema#string

Son V Pham

http://www.w3.org/2001/XMLSchema#string

Vani P Sanon

http://www.w3.org/2001/XMLSchema#string

P2860

Thin-cap fibroatheroma rupture is associated with a fine interplay of shear and wall stress

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

Structure of the human Na+/glucose cotransporter gene SGLT1

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

Active sugar transport in health and disease

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

P304

603-611

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/TCRM.S97619

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28496330

http://www.w3.org/2001/XMLSchema#string

P921

glucose

glycobiology

P932

5422533

http://www.w3.org/2001/XMLSchema#string

Differential cardiovascular profiles of sodium-glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin.

about

P2860

P2860

Differential cardiovascular profiles of sodium-glucose cotransporter 2 inhibitors: critical evaluation of empagliflozin.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932